Efficacy, tolerability and barriers to the use of anti-CGRP medications among migraine patients in Egypt: real world experience.

Aimovig (erenumab-aooe) - Amgen

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

Nurtec ODT (rimegepant ODT) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42394926

Manar Abdelazeem Gomaa; Nourhan Abdelmohsen Taha; Ramez Reda Moustafa; Shahinaz Mohamed Helmy; Sherien Mohamed Farag

Jul 4, 2026